What people are saying - Write a review
We haven't found any reviews in the usual places.
List of participants
Pathophysiology of bone metastases
Clinical aspects of the pharmacology of bisphosphonates
3 other sections not shown
300 mg daily absorption advanced breast cancer alendronate aminobisphosphonates analgesic assessment Bijvoet biochemical bisphos bisphosphonate APD bisphosphonates body retention bone formation bone metastases bone remodelling bone resorption bone turnover breast cancer breast cancer patients calcium Cancer Res carcinoma Clin clinical clodronate clodronate and pamidronate Coleman complications cytokine disodium dose of pamidronate dose-response Dr Body Dr McCloskey endocrine therapy estrogen etidronate fractures growth factor Hospital humoral hypercalcaemia hypercalcaemia hypercalcaemia of malignancy infusion Interleukin-6 intravenous pamidronate lesions lymphotoxin metastases from breast metastatic bone disease myeloma normocalcaemic Oncol oral bisphosphonates osteoclast osteoclast activity osteolysis osteolytic osteolytic agents osteolytic bone disease parathyroid hormone patients with bone patients with breast phonates potent Prostaglandins prostate cancer protein PTHrP radiotherapy randomised renal resorbing response to bisphosphonates sclerosis of lytic serum skeletal disease skeletal metastases skeleton standard therapy strontium-89 studies transforming growth treatment of bone trial tumour cells tumour-induced hypercalcaemia tumour-induced osteolysis vitro weeks